Obicetrapib lowers LDL-C in patients on high intensity statins: Results from the rose trial (NCT04753606). (August 2022) - Ray, K.K.; Nicholls, S.; Ditmarsch, M.; Kastelein, J.J.; Rigby, S.; Kling, D.; Curcio, D.; Alp, N.; Davidson, M.